tech providers
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
“Regional manufacturing
facilities crucial for suppliers”
Besides sharing his views on the current R&D trends,
manufacturing practices and market scenario pertaining to
biosupplier industry, Mr Devashish Ohri, Executive Vice President,
Asia/Middle East, Africa (MEA), Avantor in an exclusive
interaction with the Biovoice News, also provided insights into his
company’s India operations. Read the detailed interview below
BY RAHUL KOUL
What are the latest
trends in raw
material products
and technology
globally?
opportunities and
technical challenges
has increased. The
biological systems used
to manufacture these
drugs are known to be
The global market for
inherently variable, a
biologic-based
feature which has
therapeutics has
important
greatly expanded over consequences for the
the last decade. The
reproducibility, safety
emergence of the
and efficacy of the
biosimilar marketplace resulting desired
too has been
product.
significant. As a result,
Process insight and
the number of
consistency are critical
commercial
since slight changes
48
BioVoiceNews | Dec 2017 - Jan 2018
can lead to adverse
effects, such as
immunogenicity, with
potentially serious
safety implications. In
generating biosimilars,
it is crucial to ensure
that all clinically active
attributes of the
biotherapeutic,
including protein post-
translational
modifications (PTMs),
are accounted for and
confirmed.
At Avantor, we are
actively investigating